Retour sur lavenir.net
   VASTNED 30.200 € (+2,37 %)     WHAT''S COOKING GP 141.500 € (0,00 %)     ARGENX SE 682.000 € (+0,80 %)     AB INBEV 64.440 € (+1,23 %)     ACKERMANS V.HAAREN 282.600 € (-0,28 %)     BARCO 9.620 € (+1,26 %)     KBC 114.800 € (+1,10 %)     ONWARD MEDICAL 3.100 € (+3,33 %)     NYXOAH 2.435 € (-0,20 %)     KINEPOLIS GROUP 28.350 € (+2,90 %)     LOTUS BAKERIES 10 140.000 € (+0,40 %)     GIMV 46.750 € (+0,54 %)     MELEXIS 57.050 € (+3,07 %)     EVS BROADC.EQUIPM. 34.900 € (+0,29 %)     AZELIS GROUP 9.415 € (+0,16 %)     IMMOBEL 22.600 € (-1,74 %)     FAGRON 22.500 € (0,00 %)     GBL 81.000 € (+0,75 %)     BANQUP GROUP 2.850 € (0,00 %)     SOLVAC NOM(RETAIL) 73.000 € (+1,39 %)     AGEAS 67.000 € (+0,15 %)     TUBIZE-FIN 226.000 € (+1,53 %)     BPOST 1.894 € (-1,25 %)     COLRUYT 33.960 € (-0,99 %)     ASCENCIO 50.800 € (+1,60 %)     ENERGYVISION 13.350 € (+1,14 %)     WERELDHAVE BELGIUM 57.200 € (+1,42 %)     TITAN S.A. 49.260 € (+1,23 %)     INCLUSIO SA/NV 17.600 € (+0,28 %)     SEQUANA MEDICAL 0.485 € (-3,00 %)     AEDIFICA 73.500 € (+0,27 %)     SIPEF 100.000 € (-0,79 %)     SYENSQO 52.300 € (+1,95 %)     VGP 91.300 € (+0,33 %)     CELYAD ONCOLOGY 0.324 € (+2,86 %)     XIOR 27.850 € (+0,18 %)     UCB 275.000 € (+1,18 %)     AGFA-GEVAERT 0.490 € (+1,24 %)     WDP 24.040 € (-0,66 %)     CMB.TECH 10.600 € (-4,33 %)     ONTEX GROUP 2.965 € (+2,07 %)     COFINIMMO 86.450 € (+1,35 %)     DECEUNINCK 2.140 € (+1,18 %)     BREDERODE 102.600 € (-1,35 %)     MONTEA 69.400 € (+0,29 %)     PROXIMUS 7.020 € (-1,20 %)     D'IETEREN GROUP 170.800 € (-0,12 %)     DEME GROUP 184.200 € (-9,71 %)     KBC ANCORA 76.600 € (+1,59 %)     CAMPINE 220.000 € (+3,29 %)     VIOHALCO 14.320 € (+6,07 %)     CIE BOIS SAUVAGE 319.000 € (0,00 %)     UMICORE 17.550 € (+0,86 %)     SHURGARD 27.550 € (+2,99 %)     IBA 13.140 € (+2,02 %)     VAN DE VELDE 31.800 € (+0,32 %)     SOLVAY 28.380 € (+3,13 %)     OXURION 0.004 € (+10,00 %)     ECONOCOM GROUP 1.430 € (+1,78 %)     TINC 11.860 € (+0,34 %)  
   ASM INTERNATIONAL 757.800 € (+3,13 %)     SCHNEIDER ELECTRIC 260.200 € (+1,60 %)     GETLINK SE 19.650 € (-0,91 %)     PHARMING GROUP 1.477 € (+1,23 %)     ARCELORMITTAL SA 52.040 € (+2,56 %)     WORLDLINE 0.247 € (-2,02 %)     FLOW TRADERS 28.440 € (-0,42 %)     UMG 19.425 € (+3,38 %)     SOCIETE GENERALE 71.400 € (+0,72 %)     TOTALENERGIES 78.610 € (-0,33 %)     TOMTOM 4.400 € (+1,34 %)     ASML HOLDING 1 270.000 € (+2,85 %)     REXEL 38.050 € (+0,90 %)     RELX 28.360 € (-0,42 %)     UNIBAIL-RODAMCO-WE 102.450 € (-0,24 %)     BIOMERIEUX 90.200 € (+0,73 %)     GTT 199.900 € (-2,49 %)     MICHELIN 30.450 € (+0,53 %)     PHILIPS KON 24.270 € (+1,17 %)     L'OREAL 358.900 € (-0,57 %)     BUREAU VERITAS 27.210 € (+0,85 %)     LVMH 483.300 € (-0,13 %)     LEGRAND 148.850 € (+1,26 %)     ENGIE 29.130 € (-0,24 %)     AXA 41.110 € (-0,80 %)     SHELL PLC 39.265 € (-0,80 %)     EUROPLASMA 0.034 € (+150,00 %)     EXAIL TECHNOLOGIES 123.300 € (-0,40 %)     ING GROEP N.V. 24.585 € (+0,59 %)     TIKEHAU CAPITAL 17.400 € (+1,40 %)     AHOLD DEL 40.980 € (-1,28 %)     THX PHARMA 3.165 € (+2,76 %)     LACROIX GROUP 12.900 € (-0,77 %)     PERNOD RICARD 65.220 € (+0,93 %)     2CRSI 36.000 € (+10,77 %)     TKH GROUP 40.700 € (+0,99 %)     TECHNIP ENERGIES 39.120 € (-4,82 %)     SOITEC 63.740 € (+19,01 %)     MAGNUM 12.310 € (-0,32 %)     NSE 53.000 € (-0,38 %)     AIRBUS 169.500 € (-0,76 %)     ADYEN 858.800 € (-0,14 %)     PROSUS 41.555 € (-0,72 %)     WOLTERS KLUWER 62.680 € (-1,38 %)     DANONE 69.180 € (+0,76 %)     EUROFINS SCIENT. 64.160 € (+0,25 %)     JDE PEET'S 31.720 € (-0,25 %)     UNILEVER 49.670 € (-0,04 %)     FDJ UNITED 25.450 € (+0,08 %)     GENFIT 8.680 € (+8,77 %)     LECTRA 15.860 € (+2,45 %)     SANOFI 80.190 € (-0,90 %)     ALSTOM 23.150 € (+0,65 %)     CAPITAL B 0.633 € (+2,93 %)     CARREFOUR 16.360 € (+0,18 %)     ABN AMRO BANK N.V. 29.060 € (+0,62 %)     VINCI 135.650 € (-0,91 %)     NACON 0.123 € (-0,16 %)     CSG 21.600 € (-7,89 %)     KERING 276.450 € (+0,73 %)  
News Réglementées
11/04/2026 16:30

VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany

EQS-News: Varon oxygen concentrator / Key word(s): Miscellaneous
VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany

11.04.2026 / 16:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


BERLIN, April 11, 2026 /PRNewswire/ -- As respiratory care needs continue to rise across Germany, demand is increasing for safer, quieter, and more efficient oxygen therapy solutions. More users are shifting away from traditional systems such as oxygen tanks and conventional home oxygen device and moving toward advanced oxygen concentrators designed for mobility, comfort, and continuous medical support.

VARON addresses this growing need with two medical-grade solutions: the portable VP-8G and the home-use Serene 5.

Portable Oxygen Freedom with VARON VP-8G

The VP-8G portable oxygen concentrator is designed for users seeking independence from heavy oxygen equipment. As a modern alternative, it delivers reliable oxygen support in a lightweight and travel-friendly design.

Key features include:

  • Ultra-lightweight design at only 1.98 kg
  • 8-level pulse flow (1–8 settings)
  • Oxygen purity of 93% ± 3%
  • Breath-controlled pulse and fixed-frequency modes
  • Quiet operation (≤40dB at setting Level 1)
  • Replaceable battery for extended mobility
  • Compact carrying system for daily use

The VP-8G supports active lifestyles by allowing users to receive continuous oxygen therapy at home, outdoors, and while traveling.

Home Oxygen Therapy with VARON Serene 5

The Serene 5 oxygen concentrator is built for continuous oxygen therapy at home, offering a modern home oxygen device.

Key features include:

  • Medical-grade oxygen output at 93% ± 3%
  • Adjustable flow rate from 0.5 to 5 L/min
  • Ultra-quiet operation below 43 dB
  • Up to 72 hours continuous operation capability
  • Integrated 2-in-1 nebulizer function
  • LCD control panel with safety alerts
  • Easy mobility with built-in wheels

The Serene 5 is suitable for elderly users, patients with chronic respiratory conditions, pregnant women, and individuals requiring long-term oxygen support. It also works with CPAP/BiPAP therapy systems for sleep apnea management.

Growing Demand for Oxygen Therapy Solutions

Germany is experiencing a shift toward home-based healthcare and portable medical devices. This trend is driving increased demand for modern oxygen concentrators that replace outdated oxygen systems.

Both the VP-8G and Serene 5 provide a more efficient alternative to the traditional oxygen tanks offering greater portability, safety, and ease of use.

About VARON

VARON develops advanced oxygen therapy solutions designed to improve mobility, independence, and quality of life. With a focus on performance, quiet operation, and user-friendly design, VARON support modern respiratory care needs in Germany and worldwide.

Media Contact:

VARON Oxygen Concentrators

Email: support@varoninc.de 

Website: https://varoninc.de/ 

Cision View original content:https://www.prnewswire.com/de/pressemitteilungen/varon-oxygen-concentrators-meet-rising-demand-for-modern-oxygen-therapy-in-germany-302739759.html

rt.gif?NewsItemId=EN31523&Transmission_Id=202604111027PR_NEWS_EURO_ND__EN31523&DateId=20260411


11.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2306746  11.04.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière